AFA-281

AFA-281 · Afasci Inc

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for AFA-281, covering 2024-11-29 to 2025-10-21. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Single Ascending Dose and Multiple Ascending Doses of Oral AFA-281 in Healthy Volunteers [Phase 1]